00:00
07:26
Morgans Senior Analyst, Dr. Derek Jellinek, discusses the Healthcare Sector ahead of the February 2020 Reporting Season. In this update, Derek also highlights his thoughts on ResMed (ASX:RMD), CSL (ASX:CSL) and Ramsay Healthcare (ASX:RHC), considering their recent short-term price decline.

Check out more from Morgans:

Visit the Morgans website: www.morgans.com.au
Check out our blog: www.morgans.com.au/Blog

On Facebook: www.facebook.com/MorgansAU
On Instagram: www.instagram.com/Morgans.Australia
On Twitter: twitter.com/MorgansAU

#Healthcare #Stocks #ReportingSeason
Morgans Senior Analyst, Dr. Derek Jellinek, discusses the Healthcare Sector ahead of the February 2020 Reporting Season. In this update, Derek also highlights his thoughts on ResMed (ASX:RMD), CSL (ASX:CSL) and Ramsay Healthcare (ASX:RHC), considering their recent short-term price decline. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU #Healthcare #Stocks #ReportingSeason read more read less

3 years ago #add, #asx, #ausbiz, #australia, #csl, #downside, #health, #healthcare, #markets, #ramsayhealthcare, #reportingseason, #resmed, #rhc, #rmd